NZ Herald·2 min read·medium
A2 Milk secures China approval for infant formula production at Pōkeno, plans $300m dividend
✦AI Summary
A2 Milk has received regulatory approval from China to produce infant formula at its Pōkeno facility. The company also announced plans to issue a $300 million special dividend to shareholders.
Why it matters
This approval is a major milestone for the company's China growth strategy and signals strong financial health, leading to a significant boost in share price.
A2 Milk has got the nod from China to make formula at the former Yashili plant at Pōkeno. Photp / NZME
businesseconomy
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article reports on corporate financial news and regulatory updates in a straightforward, factual manner.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in